ALTERNATIVE DONOR SOURCES IN HLA-MISMATCHED MARROW TRANSPLANTATION - T-CELL DEPLETION OF SURGICALLY RESECTED CADAVERIC MARROW
- 1 May 1988
- journal article
- research article
- Vol. 3 (3) , 211-220
Abstract
Allogeneic bone marrow transplantation has been largely confined in its application to patients with an HLA-matched marrow donor, thereby limiting potential therapeutic benefits for patients with diseases amenable to treatment by marrow transplantation who lack effective alternative therapies and an identified matched marrow donor. T cells in the donor marrow generate graft-versus-host disease which is a major consideration in attempts to widen the application of allogeneic marrow transplantation to the minimally HLA-mathced or mismatched setting. The method of marrow harvest influences both the number of such T cells in the donor marrow inoculum and the functional capacity of T cells in murine marrow. We have therefore evaluated surgically resected cadaveric marrow for T cell content and for T cell depletion. Surgically resected marrow is more easily depleted of T cells than aspirated marrow and clinically useful quantities of marrow have been obtained and cryopreserved in a bank of characterized donor marrow for future use in HLA minimally matched or unmatched marrow transplantation.This publication has 25 references indexed in Scilit:
- TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY WITH HLA-A,B,D,DR INCOMPATIBLE PARENTAL MARROW-CELLS FRACTIONATED BY SOYBEAN AGGLUTININ AND SHEEP RED-BLOOD-CELLS1983
- Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.The Journal of Experimental Medicine, 1982
- Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.The Journal of Immunology, 1982
- BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONETransplantation, 1981
- Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.The Journal of Immunology, 1980
- Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans.Proceedings of the National Academy of Sciences, 1980
- Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens.The Journal of Immunology, 1980
- HUMAN T-CELL ANTIGENS DEFINED BY MONOCLONAL-ANTIBODIES - ABSENCE OF T65 ON COMMITTED MYELOID AND ERYTHROID PROGENITORS1980
- Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.Proceedings of the National Academy of Sciences, 1979
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978